 |
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
U.S. Centers for Disease Control and Prevention
• U.S. News
Vertex: HIV Drug Not as Potent as Abbott'sJuly 25, 2003 Vertex Pharmaceuticals Inc. said that its experimental AIDS
drug, GW433908, appeared less potent against HIV in a yearlong
study than Abbott Laboratories' drug, Kaletra. Vertex developed
the drug with GlaxoSmithKline, and the companies filed for Food
and Drug Administration approval of GW433908 in December.
Patients taking Kaletra had steeper reductions in HIV levels
throughout the study, Vertex said.
Adapted from:Back to other news for July 25, 2003 Boston Globe 07.25.03; Bloomberg News This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. |
E-Mail
Printable Single-Page
Glossary
Share
